# Liposomal Bupivacaine for Postoperative Pain After Craniotomy

> **NCT06701539** · NA · NOT_YET_RECRUITING · sponsor: **Beijing Tiantan Hospital** · enrollment: 106 (estimated)

## Conditions studied

- Liposome Bupivacaine

## Interventions

- **DRUG:** Liposome bupivacaine group
- **DRUG:** Ropivacaine group

## Key facts

- **NCT ID:** NCT06701539
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12-01
- **Primary completion:** 2025-06-01
- **Final completion:** 2025-12-31
- **Target enrollment:** 106 (ESTIMATED)
- **Last updated:** 2024-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06701539

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06701539, "Liposomal Bupivacaine for Postoperative Pain After Craniotomy". Retrieved via AI Analytics 2026-09-28 from https://api.ai-analytics.org/clinical/NCT06701539. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*